RxDoctor Payments Data

Kristy Marriott-Duvall

Nurse Practitioner · Perrysburg, OHNPI 1912159625

Payments from drug & device makers

$1,046in general payments, 2019–2025

Across 62 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$255
  • AbbVie$200
  • AstraZeneca$83
  • Biohaven Pharmaceutical Holding Company Ltd.$50
  • Amgen$40
  • Daiichi Sankyo Inc.$31
  • plus $388 from 17 others

What the payments were for

  • Food & beverage$1,046100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,046 in reported general payments places this provider in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$52,100
Medicare patients
165
Services billed
561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate47$53,318
OzempicSemaglutide36$45,679
EliquisApixaban41$32,301
MounjaroTirzepatide25$31,768
RybelsusSemaglutide19$24,576
TrulicityDulaglutide13$15,440
JardianceEmpagliflozin19$15,044
Aimovig AutoinjectorErenumab-Aooe13$9,454
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$8,238
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$7,450
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$6,240
Atorvastatin Calcium398$4,832
Verapamil Er PmVerapamil Hcl15$3,674
Esomeprazole Magnesium11$3,335
Albuterol Sulfate HfaAlbuterol Sulfate92$2,766

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$255$70,25655 claims
MerckJanuvia$25$53,31847 claims
Boehringer IngelheimJardiance$18$15,04419 claims
AbbVieSynthroid$200$1,14528 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Perrysburg

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →